Equities

Shockwave Medical Inc

Shockwave Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)330.13
  • Today's Change-0.75 / -0.23%
  • Shares traded1.03m
  • 1 Year change+19.28%
  • Beta1.0709
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Shockwave Medical Inc had net income fall -31.81% from 216.00m to 147.28m despite a 49.11% increase in revenues from 489.73m to 730.23m.
Gross margin86.99%
Net profit margin20.75%
Operating margin20.43%
Return on assets13.47%
Return on equity24.73%
Return on investment14.91%
More ▼

Cash flow in USDView more

In 2023, Shockwave Medical Inc increased its cash reserves by 108.35%, or 171.52m. Cash Flow from Financing totalled 600.40m or 82.22% of revenues. In addition the company generated 196.05m in cash from operations while cash used for investing totalled 625.73m.
Cash flow per share4.58
Price/Cash flow per share70.77
Book value per share20.55
Tangible book value per share16.95
More ▼

Balance sheet in USDView more

Shockwave Medical Inc has a Debt to Total Capital ratio of 49.36%, a higher figure than the previous year's 4.25%.
Current ratio13.81
Quick ratio12.61
Total debt/total equity0.9748
Total debt/total capital0.4936
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.